is there a shortage of semaglutide The market for compounded GLP-1 drugs remained robust despite the end (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with The FDA recently removed semaglutide

Clinical monitoring recommendations include: Baseline blood pressure measurement before initiating Zepbound Regular blood pressure and heart rate monitoring during dose titration (every 4-8 weeks) Assessment for orthostatic hypotension, particularly in patients taking antihypertensive medications Consideration of antihypertensive dose adjustments as weight loss progresses Monitoring of renal function and electrolytes in patients on diuretics or with significant gastrointestinal side effects Evaluation for medication-related adverse effects that might influence blood pressure (dehydration) Patients taking antihypertensive medications should be counseled about potential hypotension risk and instructed to report symptoms such as dizziness, lightheadedness, or syncope

International Journal of Biological Sciences , 20 (12), 46744690

However, the mechanism by which GLP-1 in the mesolimbic pathway reduces food or drug intake is not clear (Alhadeff et al., 2013)

Rushmore TH et al

Flexible Use: Can be taken as needed or daily for continuous effect